US equities
|
ANT
$95.06
▲+14.54%
NVDA
$147.01
▼-2.62%
AMD
$481.97
▼-9.09%
MU
$694.01
▼-1.60%
SPCX
$136.46
▼-4.91%
AMZN
$256.98
▼-4.02%
SNDK
$763.04
▼-1.70%
MSFT
$500.10
▼-1.61%
ANT
$95.06
▲+14.54%
NVDA
$147.01
▼-2.62%
AMD
$481.97
▼-9.09%
MU
$694.01
▼-1.60%
SPCX
$136.46
▼-4.91%
AMZN
$256.98
▼-4.02%
SNDK
$763.04
▼-1.70%
MSFT
$500.10
▼-1.61%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:LYRA
Recent news which mentions NASDAQ:LYRA
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 14, 2024
Tickers
LYRA
Tags
Market News
NASDAQ:LYRA
Earnings Reports
From
InvestorPlace
LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024
April 30, 2024
Tickers
LYRA
Tags
Earnings Reports
NASDAQ:LYRA
Market News
From
InvestorPlace
LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023
March 21, 2024
Tickers
LYRA
Tags
Market News
NASDAQ:LYRA
Today's Market
From
InvestorPlace